Authors:
Moore, HCF
Mick, R
Solin, LJ
Sickles, C
Mangan, PA
Luger, SM
Fox, KR
Schuchter, LM
Loh, E
Porter, DL
Schuster, S
Buzby, GP
Glatstein, E
Silberstein, LE
Stadtmauer, EA
Citation: Hcf. Moore et al., Autologous stem-cell transplant after conventional dose adjuvant chemotherapy for high-risk breast cancer: Impact on the delivery of local-regional radiation therapy, ANN ONCOL, 10(8), 1999, pp. 929-936
Authors:
Tsai, DE
Moore, HCF
Hardy, CL
Porter, DL
Loh, EY
Vaughn, DJ
Luger, S
Schuster, SJ
Stadtmauer, EA
Citation: De. Tsai et al., Rituximab (anti-CD20 monoclonal antibody) therapy for progressive intermediate-grade non-Hodgkin's lymphoma after high-dose therapy and autologous peripheral stem cell transplantation, BONE MAR TR, 24(5), 1999, pp. 521-526